 The aim of this research is to study the effects of a pomegranate juice on calprotectin levels in patients suffering of inflammatory bowel diseases IBD in clinical remission. Fecal calprotectin levels, surrogate marker of mucosal inflammation, will be measured from baseline to 12 weeks later end of intervention. Systemic and mucosal changes of biochemical and molecular inflammatory response markers will be also assessed. 